↓ Skip to main content

Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer

Overview of attention for article published in Frontiers in Pharmacology, June 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
3 X users
peer_reviews
1 peer review site

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
1 Mendeley